Company intelligence / Profile preview

Algatek

Indonesia

Ownership: Private
Development stage: Other

Overview

Algatek has introduced a microalgae-based photobioreactor platform that captures 40–60% of CO₂ emissions from diesel power plants, converting them into green hydrogen and oxygen. Their innovation is commercially deployed for environmental and energy applications rather than human therapeutics.

Modalities: Device
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Algatek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algatek.

Explore the full profile